For: | Lin C, Li ZL, Cai XL, Hu SY, Lv F, Yang WJ, Ji LN. Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2023; 14(10): 1573-1584 [PMID: 37970134 DOI: 10.4239/wjd.v14.i10.1573] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i10/1573.htm |
Number | Citing Articles |
1 |
Kotha Sugunakar Reddy, Archana Gaur, Sakthivadivel Varatharajan, Arvind Kumar Morya. Chiglitazar and Thiazolidinedione in patients with type 2 diabetes: Which is better?. World Journal of Diabetes 2024; 15(3): 565-567 doi: 10.4239/wjd.v15.i3.565
Abstract(291) |
Core Tip(329) |
Full Article(HTML)(784)
|
Full Article with Cover (PDF)-714K(95)
|
Full Article (Word)-35K(0)
|
Audio-1539K(2)
|
Peer-Review Report-219K(27)
|
Answering Reviewers-49K(32)
|
Full Article (PDF)-329K(100)
|
Full Article (XML)-21K(32)
|
Times Cited (0)
|
Total Visits (2175)
|
Open
|
2 |
Sujun Xiao, Mingxu Qi, Qinyi Zhou, Huiqin Gong, Duhui Wei, Guangneng Wang, Qilun Feng, Zhou Wang, Zhe Liu, Yiren Zhou, Xiaofeng Ma. Macrophage fatty acid oxidation in atherosclerosis. Biomedicine & Pharmacotherapy 2024; 170: 116092 doi: 10.1016/j.biopha.2023.116092
|